Non-invasive markers for sudden cardiac death risk stratification in dilated cardiomyopathy

Area of Science:

• Cardiology
• Cardiac Electrophysiology
• Medical Imaging

Background:

• Dilated cardiomyopathy (DCM) is a prevalent cardiac condition with significant challenges in predicting sudden cardiac death (SCD).
• While heart failure prognosis has improved, SCD due to ventricular arrhythmias remains a major concern in DCM.
• Current risk stratification methods for SCD, relying on left ventricular ejection fraction and NYHA class, have limitations in identifying high-risk patients for implantable cardioverter defibrillators (ICDs).

Purpose of the Study:

• To review current guideline-directed risk markers for SCD in DCM.
• To explore novel imaging, electrophysiological, and genetic markers for improved SCD risk prediction.
• To enhance the effectiveness of ICD therapy by better identifying patients who will benefit.

Main Methods:

• Literature review of current SCD risk stratification guidelines and trials in DCM.
• Exploration of emerging research on advanced imaging techniques.
• Investigation of electrophysiological studies and genetic markers for SCD risk.

Main Results:

• Current markers (LVEF, NYHA class) show modest efficacy in predicting appropriate ICD therapy.
• Newer markers from imaging, electrophysiology, and genetics show promise for improved risk stratification.
• There is a need for more precise methods to identify DCM patients at high risk of SCD.

Conclusions:

• Improved SCD risk stratification in DCM is crucial for optimizing ICD therapy and reducing preventable mortality.
• Novel imaging, electrophysiological, and genetic markers represent promising avenues for future risk assessment.
• Further research is needed to validate and integrate these new markers into clinical practice for DCM management.